Negotiated procedure without prior publication of a tender notice for the supply of the exclusive drug Truqap® (capivasertib) required by ASUIT.

This tender concerns a negotiated procedure initiated without a prior public tender announcement, as per Article 76, paragraph 2, letter b) of Legislative Decree No. 36/2023. The contract is for the supply of the exclusive drug Truqap® (capivasertib) to the Azienda Sanitaria Universitaria Integrata del Trentino (ASUIT). The CPV code is for various medicinal products, and the contract type is supplies. The procedure was a negotiated one without prior tender publication, held in Trento. The estimated value was EUR 2,376,000.00, and the contract was awarded to ASTRAZENECA for the full estimated amount. The specific product details are Truqap® 64 tablets of 160mg-200mg, with AIC 051358012-051358024, highlighting a significant procurement of a specialized pharmaceutical for cancer treatment.

This is a supplies contract in the general supplies sector. Located in Italy, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 2.4 million.

Published through ANAC (Italy), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the general supplies sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.